Michael G. Bator - Aug 10, 2022 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role
Director
Signature
/s/ Kathleen P. Bloch attorney-in-fact Michael G. Bator
Stock symbol
CTSO
Transactions as of
Aug 10, 2022
Transactions value $
$0
Form type
4
Date filed
8/12/2022, 06:51 PM
Previous filing
May 19, 2022
Next filing
Jul 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTSO Common Stock 84.8K Aug 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTSO Stock Option (right to buy) Award $0 +19K $0.00 19K Aug 10, 2022 Common Stock 19K $1.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (a) the following restricted stock units which will vest upon a "Change of Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (i) 3,300 restricted stock units granted on March 15, 2018, (ii) 6,000 restricted stock units granted on February 24, 2017, and (iii) 60,000 restricted stock units granted on June 7, 2017, and (b) 15,500 shares of common stock owned by the reporting person
F2 The stock options were granted pursuant to the Plan. The shares underlying the stock options will vest in four equal parts on 8/10/2022, 9/30/2022, 12/31/2022 and 3/31/2023, subject to the reporting person's continued service as of the applicable vesting date.